ALKS

NASDAQ · Biotechnology

Alkermes Plc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$45.08

-0.81 (-1.77%)

As of Nov 5, 8:03 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 19 73%

Hold 6 23%

Sell 1 4%

Price Target

Analyst Price Target +180.4% upside

Low Target $90.34

Average Target $126.40

High Target $146.79

Current Price $45.08

Current
$45.08

Target
$126.40

$90.34 $126.40 avg $146.79

Scenario Analysis

Bear Case

$90.34

100.4%

Low target

Base Case

$126.40

+180.4%

Avg target

Bull Case

$146.79

+225.6%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$55.67

-19.0% from high

52-Week Low

$27.00

+67.0% from low

50-Day SMA

$43.86

+2.8% vs SMA

200-Day SMA

$40.68

+10.8% vs SMA

RSI (14)

81.0

Overbought

Target vs 52W High

$126.40

+127.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%